52 results about "Vitreous opacity" patented technology

The invention discloses a lutein ester health care product for protecting eyesight. The lutein ester health care product is prepared by taking lutein ester as a main material, and adding any one or more materials including taurine, selenium, zinc, alpha-lipoic acid, docosahexaenoic acid (DHA), vitamin A, vitamin E, vitamin B1, vitamin B2 and bilberry extract, and pharmaceutically acceptable formulation accessories. The outstanding innovation of the invention is the implementation of the method for preparing a functional eye health care product with the lutein ester instead of lutein, so that the bioavailability, the stability and the health care effect of the product are improved, and production cost can be greatly reduced. The health care product can be prepared into common dosage forms, such as tablets, capsula, granules and soft capsules. The lutein ester health care product is mainly used for the treatment on diseases, such as myopia, amblyopia, hyperopia, presbyopia, cataract, vitreous opacity, retinal pigment degeneration, macular degeneration, asthenopia, and retinopathy caused by diabetes, and the like. The lutein ester health care product adopts a unique formulation of multiple constituents, measures and mechanisms, and has significant treatment effects and excellent social and economic benefits.

A composition and method for treating dry-eye syndrome and symptoms of vitreous opacities in a host comprising the oral administration of a composition which contains a pharmacologically effective amount of essential fatty acids, polar phospholipids, vitamins, minerals and dietary supplements.

The invention discloses a medicament for improving eyesight. In the medicament, szechuan tangshen root, astragalus, large-headed atractylodes, Chinese angelica, rehmanniae vaporata, red paneoy root, rehmanniae praeparatum, gardenia fruit, medlar, eucommia bark, south dodder seed, raspberry, root of red-rooted salvia, notoginseng root, pale butterflybush flower, blackend swallowwort root, fish poison yarn and chrysanthemum are ground into 200-mesh powder, and are mixed uniformly, sterilized and packaged, wherein each bag contains 5 grams of medicament. The medicament is mainly used for treating patients who suffer from blurred vision caused by symptoms such as deficiency in kidney and yang, deficiency in blood and qi, diabetes mellitus, retinopathy, fundus hemorrhage, vitreous opacity, glaucoma or optic nerve pathological changes and the like, and 50 patients who suffer from the blurred vision are selected in the outpatient service of a hospital randomly to take the medicament. In the administration method and dosage, adults take twice every day, and takes 5 grams every time; for the children, the dosage is reduced by half; and 20 days is one treatment course, the total cure rate is 69 percent, the total cure rate of two treatment courses is 86.3, and the cure rate of three treatment course is 97.2 percent.

The invention relates to a Chinese medicament for treating cataract and glaucoma. The invention adopts the technical proposal that the medicament is prepared from the following raw materials by weight portion: 10 to 30 portions of cassia seed, 10 to 30 portions of dodder, 10 to 30 portions of angelica dahurica, 10 to 30 portions of magnetite, 5 to 15 portions of broom cypress fruit, 5 to 15 portions of bat faece, 30 to 50 portions of medicated leaven, and 30 to 50 portions of bamboo leaves. A preparation method comprises the following steps: crushing the magnetite and the bat faece according to the proportion, and sieving the crushed magnetite and bat faece by a sieve of 100 meshes; adding the cassia seed, the dodder, the angelica dahurica, the broom cypress fruit, the medicated leaven and the medicated leaven into a container, adding 8 times of water accounting for the total weight of the six gouts of Chinese medicament into the container, extracting the mixture for 1.5 to 2.5 hours, filtering the mixture, and taking medicinal liquid; adding 6 times of water into the rest residue, extracting the residue for 1 to 2 hours, filtering the residue, and taking the medicinal liquid; combining the twice medicinal liquids, condensing the medicinal liquid, drying the medicinal liquid in vacuum, and crushing the dried substance; and evenly mixing the dried substance and the crushed magnetite and bat faece. The Chinese medicament has good treatment effect on eye diseases such as cataract, glaucoma, vitreous opacity, floaters symptom, and the like.

The invention relates to a multi-dimensional xanthophyll preparation for powerfully protecting eyesight, which is prepared from raw materials consisting of xanthophyll, taurine, selenium, alpha-lipoic acid, L-ascorbic acid, beta-carotene, DHEA, a grape seed extract and pyridoxine hydrochloride and auxiliary materials in a certain proportion. The preparation can be prepared into tablets, capsules, granules, oral liquid, pills and other common formulations. The preparation is mainly used for myopia, amblyopia, hyperopia, presbyopia, cataract, vitreous opacity, retinitis pigmentosa, macular degeneration, asthenopia, diabetic retinopathy and the like. The preparation adopts a multi-component, multi-path and multi-mechanism unique formula and has obvious treatment effect and positive popularization value.

The invention discloses an axis oculi length measuring device and an axis oculi length measuring method. The axis oculi length measuring device comprises a light source, a spectroscopical module, a reference arm module, a sample arm module and a detection module. According to the axis oculi length measuring device disclosed by the invention, measurement of axis oculi length is realized through thenature of OCT, and the disadvantage that an optical related biomeasuring instrument easily measures a patient suffering from vitreous opacity wrongly is overcome; one beam of detection light is separated into two beams of detection light through a sample arm, the two beams of the detection light are respectively focused on a cornea and a retina for simultaneous scanning, and images are simultaneously obtained; the optical axes of the two beams of the detection light are coaxial, so that the measuring result is free from the influence of eye movement; for the patient suffering from vitreous opacity, the light penetrating power of eyes is weakened, but final measuring accuracy cannot be influenced; and besides, the measuring method provided by the invention combines equipment for measuringaxis oculi length with OCT equipment, so that the situation that which layer of the retina the specific measuring position on the retina is located on can be more intuitively seen.

The invention discloses a method for processing a condensed pill for treating eye disease. Medicinal prescription of 3000 condensed pills comprises the following components of 10-15g of pearl powder from bred mussels, 15-20g of cloud notoginseng powder, 5-10g of fructus viticis, 8-10g of selfheal spike, 8-10g of angelica sinensis, 5-10g of ligusticum wallichii and the like. The product pill is prepared by the processes of decocting crude drugs, crushing raw materials, refining old honey and the like. The vision of a sufferer can be effectively improved; muscae volitantes and clumps ghosting of the affected eye caused by vitreous opacities can be removed; middle concurrency cataracts caused by lens opaque can be effectively reversed; bulbi hypertonia of the affected eye caused by secondary glaucoma can be reversely reduced to within a normal value of 10-21mmHg; and the pain of the sufferer during extraction eyeball by a western medicine surgery is removed. Therefore, the medical problem that difficult eye diseases cannot be solved by western medicine at present is overcome.

The present invention relates to a traditional Chinese medicine for treating eye diseases, in particular to a traditional Chinese medicine preparation for treating retinal hemorrhage and vitreous opacity. The present invention is composed of the pharmaceutical raw materials with the following parts by weight: danshen root 30, kudzuvine root 15, cassia seed 15, south dodder seed 15, cattail pollen 10, swordlike atractylodes rhizome 10, seaweed 10, kelp 10, baical skullcap root 6 and sanchi powder 2. Compared with the former obtained patent ZL03104746.7 by the applicant, the prescription composition of the present invention eliminates three traditional Chinese medicines of sea-ear shell, nacre and medicinal cyathula root, increases one medicine of kudzuvine root and adjusts the parts by weight of all the traditional Chinese medicines in the prescription composition. The modern pharmacological studies show that the puerarin contains flavonoids, which can improve the microcirculation, enhance the red cell deformability, reduce the aggregation, improves the blood flow, increase the local microcirculation blood flow and inhibit the platelet aggregation. Therefore, the prescription composition of the medicine is more scientific and reasonable; and the efficacy is more significant through the clinical observations in the past four years.

According to the MDP-net-based vitreous opacity grading screening method and device, a crystalline lens, a quasi-trapezoidal vitreous cavity and a turbid focus area in an eye vitreous ultrasonic image can be segmented through deep learning by an eye vitreous ultrasonic image adaptive segmentation model and a severity classification algorithm; according to the method, the vitreous opacity severity of the patient can be quickly and accurately judged and screened after image training by applying the deep learning technology, and the obtained result is quick, objective, accurate and stable.

The invention discloses an eye drops and preparing method to treat cataract for person in middle and old age and vitreous opacity, which is made of sulfur puluonin and corresponding auxiliary materials. The invention has relatively stable quality and effect to be carried and intaked safely and heathly, which improves the quality standard and enlarges the drug kinds to satisfy the need of the people for drugs.

The invention discloses a pharmaceutical composition for treating vitreous opacity and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from the raw material medicines including eucalyptus fruits, common anotis herb, hederagenin, glepidotin C and saikoside in proportion, can be prepared into various dose forms by virtue of conventional preparation processes and has a remarkable effect to the treatment of the vitreous opacity.

The invention relates to a traditional Chinese medicinal compound for treating ophthalmology diseases, in particular for treating eye ground hemorrhage vitreous opacity, wherein the ingredients and weight proportions of the medicament are, radix salvia miltiorrhiza 12.86-19.29, sea-ear shell and Cassia occidentalis semen cassiae torae each 9.65-19.29, ruby mica 3.22-19.29, sea weed and sea apron each 3.86-7.72, notoginseng powder, cattail pollen, and baikal skullcap root each 1.93-6.43, doddor seed 6.43-9.65, cyathula root 3,86-9.65, atractylodes rhizome 3.22-6.43.

The invention belongs to a traditional Chinese medicine, specifically to a vitreous opacity and hemorrhage treatment traditional Chinese medicine, which is characterized by comprising, by weight, 10-20 g of rehmannia glutinosa libosch, 5-15 g of cornus officinalis, 5-15 g of cortex moutan, and 5-15 g of tuckahoe, wherein the selected rehmannia glutinosa libosch, the selected cornus officinalis, the selected cortex moutan and the selected tuckahoe are washed, are subjected to air-drying, and are grinded into fine powder with a particle size of 100 mesh, and the one part of the obtained drug powder is directly and orally taken twice a day. According to the present invention, based on the Chinese medical science syndrome differentiation theory, characteristics of simple formula, easily available materials, low cost, high treatment effect, no toxic-side effect and effective vitreous opacity and hemorrhage treatment are provided.

The invention discloses a medicinal decoction for treating vitreous opacities and fundus hemorrhage and a preparation method. The medicinal decoction comprises the following components in parts by mass: 1 to 3 parts of rhizome of rehmannia, 1 to 3 parts of cornus officinalis, 1 to 3 parts of cortex moutan, 1 to 3 parts of rhizoma alismatis, 1 to 3 parts of wolfiporia extensa, 1 to 3 parts of astragali complanati semen, 1 to 3 parts of plantain seeds, 1 to 3 parts of medlar, 1 to 3 parts of dendrobium nobile, 1 to 3 parts of Chinese thorowax roots, 1 to 3 parts of scutellaria baicalensis, 1 to 3 parts of green tangerine peel, 1 to 3 parts of radix aucklandiae, 1 to 3 parts of motherwort fruits and 1 to 3 parts of raw licorice. The preparation method for the medicinal decoction comprises the steps of selecting first-grade rhizome of rehmannia, cornus officinalis, cortex moutan, rhizoma alismatis, wolfiporia extensa, astragali complanati semen, plantain seeds, medlar, dendrobium nobile, Chinese thorowax roots, scutellaria baicalensis, green tangerine peel, radix aucklandiae, motherwort fruits and raw licorice, removing residual impurities from the components except the plantain seeds which are additionally packaged, for later use; loading the medicaments in a cloth bag, closing an opening of the cloth bag, impregnating the medicaments for half an hour in cooled boiled water, loading the impregnated medicaments in a decocting machine, injecting cooled boiled water which is sufficient to impregnate the medicaments by 5 centimeters, performing primary decoction for 35 minutes, filtering liquid medicine, adding slightly warm boiled water, performing secondary decoction for 25 minutes, and mixing and concentrating the liquid medicine to obtain 1,620 milliliters of 50 percent traditional Chinese liquid medicine.

The present invention discloses a Chinese patent medicine for curing ophthalmopathies of various cataracts and external oculopathy and other diseases of vitreous opacity and pain of eye. Said medicine is a powder preparation transnasal administration, and its effective rate is 100%. Said medicine is made up by using ephedra root, Chinese angelica root and musk through a certain preparation process.

The invention relates to the technical field of traditional Chinese medicines, and discloses a traditional Chinese medicine for effectively treating insomnia and a decoction method. The traditional Chinese medicine is prepared from the following components in parts by weight: 18-36 parts of antelope's horns, 12-24 parts of bear galls, 15-20 parts of pearl, 6-12 parts of ginseng, 15-20 parts of caltrop, 10-20 parts of glossy privet fruit, 10-20 parts of chrysanthemum, 20-30 parts of dendrobe, 10-20 parts of equisetum hyemale, 10-20 parts of dogwood, 10-20 parts of cuscuta chinensis and 9-17 parts of lycium barbarum. The traditional Chinese medicine is capable of effectively treating eye diseases such as glaucoma, cataract, vitreous opacity, fundus hemorrhage, optic atrophy, conjunctivitis, keratitis, iritis, epiphora induced by wind, juvenile myopia, hyperopia and amblyopia.